What is the Return on Assets (ROA) of Transgene this year?
The Return on Assets (ROA) of Transgene is -0.49 undefined this year.
Transgene ROA 2024
Transgene ROA
-0.49
Ticker
TNG.PA
ISIN
FR0005175080
WKN
913048
In 2024, Transgene's return on assets (ROA) was -0.49, a 0.01% increase from the -0.49 ROA in the previous year.
Transgene Aktienanalyse
What does Transgene do?
Transgene SA is a French biotechnology company specializing in the development and production of therapeutics, with a focus on cancer medications. It has a strong patent portfolio in the field of viral vectors, which are used for targeted gene therapy. The company's main areas of operation are clinical trials, research, and production. Transgene has research and production facilities in Strasbourg and Lyon, with over 100 employees. It has established partnerships with pharmaceutical companies, including Takeda Pharmaceuticals, for the development and marketing of therapeutics. Its flagship product, OncoVir-1®, is an immunomodulator that stimulates the immune system to fight tumor cells. Another promising product is TG4010, a therapeutic vaccine for non-small cell lung carcinoma. Transgene is an emerging company with a promising portfolio of cancer therapeutics, leveraging its expertise in viral vectors and collaborating closely with industry partners to expedite the development of marketable products. Transgene is expected to play a significant role in the development of new and innovative cancer treatments. Transgene ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Transgene's Return on Assets (ROA)
Transgene's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Transgene's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Transgene's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Transgene’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Transgene stock
What was the ROA of Transgene compared to the previous year?
The ROA of Transgene has increased by 0.01% compared to the previous year.
What consequences do high ROA have for investors of Transgene?
A high ROA is advantageous for investors of Transgene, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Transgene?
A low ROA can be unfavorable for investors of Transgene as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Transgene affect the company?
An increase in ROA of Transgene can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Transgene impact the company?
A reduction in the ROA of Transgene can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Transgene?
Some factors that can influence the ROA of Transgene include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Transgene important for investors?
The ROA of Transgene is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Transgene take to improve ROA?
To improve ROA, Transgene can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Transgene pay?
Over the past 12 months, Transgene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transgene is expected to pay a dividend of 0 EUR.
What is the dividend yield of Transgene?
The current dividend yield of Transgene is .
When does Transgene pay dividends?
Transgene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Transgene?
Transgene paid dividends every year for the past 0 years.
What is the dividend of Transgene?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Transgene located?
Transgene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Transgene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Transgene from 9/26/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did Transgene pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of Transgene in the year 2023?
In the year 2023, Transgene distributed 0 EUR as dividends.
In which currency does Transgene pay out the dividend?
The dividends of Transgene are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Transgene stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Transgene
Our stock analysis for Transgene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Transgene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
